Significant differences in the decision making process exist between melanoma patients who accept or decline high-dose adjuvant interferon-alpha-2B therapy
Publication
, Journal Article
Freedman, SA; Bialy, T; Abramova, L; Chen, S
Published in: Journal of the American Academy of Dermatology
March 2004
Duke Scholars
Published In
Journal of the American Academy of Dermatology
DOI
ISSN
0190-9622
Publication Date
March 2004
Volume
50
Issue
3
Start / End Page
P5 / P5
Publisher
Elsevier BV
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Freedman, S. A., Bialy, T., Abramova, L., & Chen, S. (2004). Significant differences in the decision making process exist between melanoma patients who accept or decline high-dose adjuvant interferon-alpha-2B therapy. Journal of the American Academy of Dermatology, 50(3), P5–P5. https://doi.org/10.1016/j.jaad.2003.10.023
Freedman, Stacey A., Tracy Bialy, Liana Abramova, and Suephy Chen. “Significant differences in the decision making process exist between melanoma patients who accept or decline high-dose adjuvant interferon-alpha-2B therapy.” Journal of the American Academy of Dermatology 50, no. 3 (March 2004): P5–P5. https://doi.org/10.1016/j.jaad.2003.10.023.
Freedman SA, Bialy T, Abramova L, Chen S. Significant differences in the decision making process exist between melanoma patients who accept or decline high-dose adjuvant interferon-alpha-2B therapy. Journal of the American Academy of Dermatology. 2004 Mar;50(3):P5–P5.
Freedman, Stacey A., et al. “Significant differences in the decision making process exist between melanoma patients who accept or decline high-dose adjuvant interferon-alpha-2B therapy.” Journal of the American Academy of Dermatology, vol. 50, no. 3, Elsevier BV, Mar. 2004, pp. P5–P5. Crossref, doi:10.1016/j.jaad.2003.10.023.
Freedman SA, Bialy T, Abramova L, Chen S. Significant differences in the decision making process exist between melanoma patients who accept or decline high-dose adjuvant interferon-alpha-2B therapy. Journal of the American Academy of Dermatology. Elsevier BV; 2004 Mar;50(3):P5–P5.
Published In
Journal of the American Academy of Dermatology
DOI
ISSN
0190-9622
Publication Date
March 2004
Volume
50
Issue
3
Start / End Page
P5 / P5
Publisher
Elsevier BV
Related Subject Headings
- Dermatology & Venereal Diseases
- 3202 Clinical sciences
- 1103 Clinical Sciences